Understanding the limitations upfront prevents frustration later
Sexual dysfunctions induced by stress of timed intercourse and medical treatment
Heres a little trick I recommend that will help you pick and choose indulgences: It's called the two-week test
This transition in the sexual health category should continue in 2026, and while this may pressure Subscriber growth in the short-term, getting more Subscribers to use daily sexual health offerings results in better retention, and thus higher-quality, more stable sales growth
Patients with pre-existing myopathy risk factors
Pfizer's danuglipron, once considered the primary competitor, was discontinued in April 2025 after a case of potential drug-induced liver injury in a dose-optimization study, following the earlier termination of lotiglipron in 2023 for similar hepatic concerns